Emerging Epigenetic Therapies for the Treatment of Cardiac Fibrosis
Fibrosis is a pathological process characterized by excessive extracellular matrix (ECM) deposition, leading to tissue stiffening and organ dysfunction. It is a major contributor to chronic diseases affecting various organs, with limited therapeutic options available. Among the different forms of fi...
Saved in:
| Main Authors: | Nerea Garitano, Laura Pilar Aguado-Alvaro, Beatriz Pelacho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1170 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic modifications in cardiac fibrosis: recent evidence of new pharmacological targets
by: Marian Pérez, et al.
Published: (2025-05-01) -
Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
by: Rachel M. Biggs, et al.
Published: (2025-04-01) -
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-09-01) -
TFAP4 exacerbates pathological cardiac fibrosis by modulating mechanotransduction
by: Jie Liu, et al.
Published: (2025-08-01) -
Characterizing the Impact of Fabrication Methods on Mechanically Tunable Gelatin Hydrogels for Cardiac Fibrosis Studies
by: Jordyn Folh, et al.
Published: (2025-07-01)